Catalyst Wire Dossier Catalyst Wire Dossier

Dificid (fidaxomicin)

fidaxomicin · Merck & Co.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dificid (fidaxomicin), covering 2014-05-21 to 2014-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects [Phase 1]

See pricing